These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 28651155)

  • 1. Covalent inhibitors design and discovery.
    De Cesco S; Kurian J; Dufresne C; Mittermaier AK; Moitessier N
    Eur J Med Chem; 2017 Sep; 138():96-114. PubMed ID: 28651155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Covalent inhibitors: an opportunity for rational target selectivity.
    Lagoutte R; Patouret R; Winssinger N
    Curr Opin Chem Biol; 2017 Aug; 39():54-63. PubMed ID: 28609675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structural modification of natural products for novel drug discovery.
    Yao H; Liu J; Xu S; Zhu Z; Xu J
    Expert Opin Drug Discov; 2017 Feb; 12(2):121-140. PubMed ID: 28006993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Following the Lead from Nature with Covalent Inhibitors.
    Lagoutte R; Winssinger N
    Chimia (Aarau); 2017 Oct; 71(10):703-711. PubMed ID: 29070414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Theory and applications of covalent docking in drug discovery: merits and pitfalls.
    Kumalo HM; Bhakat S; Soliman ME
    Molecules; 2015 Jan; 20(2):1984-2000. PubMed ID: 25633330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protocol for rational design of covalently interacting inhibitors.
    Schmidt TC; Welker A; Rieger M; Sahu PK; Sotriffer CA; Schirmeister T; Engels B
    Chemphyschem; 2014 Oct; 15(15):3226-35. PubMed ID: 25251382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery for a new generation of covalent drugs.
    Kalgutkar AS; Dalvie DK
    Expert Opin Drug Discov; 2012 Jul; 7(7):561-81. PubMed ID: 22607458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Covalent Docking in Drug Discovery: Scope and Limitations.
    Scarpino A; Ferenczy GG; Keserű GM
    Curr Pharm Des; 2020; 26(44):5684-5699. PubMed ID: 33155894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent Inhibition in Drug Discovery: Filling the Void in Literature.
    Bjij I; Olotu FA; Agoni C; Adeniji E; Khan S; El Rashedy A; Cherqaoui D; Soliman MES
    Curr Top Med Chem; 2018; 18(13):1135-1145. PubMed ID: 30068277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive review on various strategies for antimalarial drug discovery.
    Mishra M; Mishra VK; Kashaw V; Iyer AK; Kashaw SK
    Eur J Med Chem; 2017 Jan; 125():1300-1320. PubMed ID: 27886547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Covalent simulations of covalent/irreversible enzyme inhibition in drug discovery: a reliable technical protocol.
    Khan S; Bjij I; Olotu FA; Agoni C; Adeniji E; S Soliman ME
    Future Med Chem; 2018 Oct; 10(19):2265-2275. PubMed ID: 30273013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covalent Versus Non-covalent Enzyme Inhibition: Which Route Should We Take? A Justification of the Good and Bad from Molecular Modelling Perspective.
    Aljoundi A; Bjij I; El Rashedy A; Soliman MES
    Protein J; 2020 Apr; 39(2):97-105. PubMed ID: 32072438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An overview of molecular hybrids in drug discovery.
    Bérubé G
    Expert Opin Drug Discov; 2016; 11(3):281-305. PubMed ID: 26727036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applied metabolomics in drug discovery.
    Cuperlovic-Culf M; Culf AS
    Expert Opin Drug Discov; 2016 Aug; 11(8):759-70. PubMed ID: 27366968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular approaches towards development of purified natural products and their structurally known derivatives as efficient anti-cancer drugs: current trends.
    Saha SK; Khuda-Bukhsh AR
    Eur J Pharmacol; 2013 Aug; 714(1-3):239-48. PubMed ID: 23819913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophilic warheads in covalent drug discovery: an overview.
    Péczka N; Orgován Z; Ábrányi-Balogh P; Keserű GM
    Expert Opin Drug Discov; 2022 Apr; 17(4):413-422. PubMed ID: 35129005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covalent inhibitors in drug discovery: from accidental discoveries to avoided liabilities and designed therapies.
    Bauer RA
    Drug Discov Today; 2015 Sep; 20(9):1061-73. PubMed ID: 26002380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modeling covalent-modifier drugs.
    Awoonor-Williams E; Walsh AG; Rowley CN
    Biochim Biophys Acta Proteins Proteom; 2017 Nov; 1865(11 Pt B):1664-1675. PubMed ID: 28528876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of innovative small molecule therapeutics.
    Abou-Gharbia M
    J Med Chem; 2009 Jan; 52(1):2-9. PubMed ID: 19072120
    [No Abstract]   [Full Text] [Related]  

  • 20. Systems pharmacology strategies for anticancer drug discovery based on natural products.
    Luo F; Gu J; Chen L; Xu X
    Mol Biosyst; 2014 Jul; 10(7):1912-7. PubMed ID: 24802653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.